SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-14-001392
Filing Date
2014-04-14
Accepted
2014-04-14 16:32:40
Documents
2
Period of Report
2014-04-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_041413.htm 8-K 29088
2 2014 STOCK INCENTIVE PLAN ex-10_42.htm EX-10.42 123698
  Complete submission text file 0001387131-14-001392.txt   154312
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 133709558 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 14762848
SIC: 2834 Pharmaceutical Preparations